Zurück zu Longevity
Longevity

SarkopenieStudienlage & Dosis

Altersbedingter Muskelverlust — Krafttraining + Protein als beste Prävention.

Studienlage in Zahlen

Studien gesamt
1.000
Mit Abstract
46
Meta / Systematic / RCT
2
Häufig zitiert
15
Erscheinungsjahre
1991–2026

Sarkopenie im Kontext von Longevity

Dieses Thema ist Teil unserer Welt „Longevity". Dort findest du Methodik, Studienlage und Hebel mit dem größten Effekt — sowie die Reihenfolge, in der sich Hebel sinnvoll aufeinander aufbauen.

Zur Welt Longevity

Top-Studien zu Sarkopenie

Sortiert nach einflussreichen Zitationen und Erscheinungsjahr.

  1. Epidemiology of sarcopenia among the elderly in New Mexico.

    American journal of epidemiology1998n=199200 einflussreiche Zitationen

    Muscle mass decreases with age, leading to "sarcopenia," or low relative muscle mass, in elderly people. Sarcopenia is believed to be associated with metabolic, physiologic, and functional impairments and disability. Methods of estimating…

  2. Epidemiology of sarcopenia: Prevalence, risk factors, and consequences.

    Metabolism: clinical and experimental2023200 einflussreiche Zitationen

    Sarcopenia is a geriatric condition featured by a progressive loss of muscle mass and function and associated with various adverse health outcomes. In this review, we aimed to summarize the epidemiological features of sarcopenia as well as…

  3. Osteosarcopenia: epidemiology, diagnosis, and treatment-facts and numbers.

    J Cachexia Sarcopenia Muscle2020n=235other200 einflussreiche Zitationen

    BACKGROUND: Osteosarcopenia, the presence of osteopenia/osteoporosis and sarcopenia, is an emerging geriatric giant, which poses a serious global health burden. METHODS AND RESULTS: The prevalence of osteosarcopenia ranges in…

  4. Health outcomes of sarcopenia: a consensus report by the outcome working group of the Global Leadership Initiative in Sarcopenia (GLIS).

    Aging clinical and experimental research2025200 einflussreiche Zitationen

    The Global Leadership Initiative in Sarcopenia (GLIS) aims to standardize the definition and diagnostic criteria for sarcopenia into one unifying, common classification. Among other actions to achieve this objective, the GLIS has organized…

  5. Diagnostic Criteria and Measurement Techniques of Sarcopenia: A Critical Evaluation of the Up-to-Date Evidence.

    Nutrients2024Review183 einflussreiche Zitationen

    Sarcopenia, a geriatric syndrome characterized by progressive skeletal muscle mass and function decline, poses a significant health risk among the elderly, contributing to frailty, falls, hospitalization, loss of independence and…

  6. From mitochondria to sarcopenia: role of 17β-estradiol and testosterone.

    Front Endocrinol (Lausanne)2023Review58 einflussreiche Zitationen

    Sarcopenia, characterized by a loss of muscle mass and strength with aging, is prevalent in older adults. Although the exact mechanisms underlying sarcopenia are not fully understood, evidence suggests that the loss of mitochondrial…

  7. Creatine supplementation for older adults: Focus on sarcopenia, osteoporosis, frailty and Cachexia.

    Bone2022review51 einflussreiche Zitationen

    Sarcopenia refers to the age-related reduction in strength, muscle mass and functionality which increases the risk for falls, injuries and fractures. Sarcopenia is associated with other age-related conditions such as osteoporosis, frailty…

  8. Defining sarcopenia: some caveats and challenges.

    Curr Opin Clin Nutr Metab Care2020Review47 einflussreiche Zitationen

    PURPOSE OF REVIEW: To summarize the latest advances and caveats in defining sarcopenia and discuss the implications of the most recent worldwide initiatives which are trying to harmonize the definition. RECENT FINDINGS: The evolution over…

  9. Nutritional strategies for improving sarcopenia outcomes in older adults: A narrative review.

    Pharmacol Res Perspect2024review46 einflussreiche Zitationen

    Sarcopenia is characterized by a decline in muscle strength, generalized loss of skeletal muscle mass, and impaired physical performance, which are common outcomes used to screen, diagnose, and determine severity of sarcopenia in older…

  10. Sarcopenia--mechanisms and treatments.

    J Geriatr Phys Ther2009review25 einflussreiche Zitationen

    BACKGROUND: Sarcopenia is a consequence of aging. This atrophic event is responsible for decrease in strength and associated functional deficits seen in the aging adult. PURPOSE: This paper reviews: (1) the mechanisms contributing to…

Häufige Fragen

Welche Dosierung wurde in den Studien untersucht?
• None (Not applicable)
Für welche Population gilt die Evidenz?
Die meisten Studien untersuchten: unknown.
Gibt es Sicherheitshinweise zu Sarkopenie?
• No intervention or adverse events reported; review of observational data only. • None reported; review article. • Not reported; this is a review article. • Not reported in the abstract.

Weitere Themen in Longevity

Zone 2

Niedrig-intensives Cardio — mitochondriale Biogenese, Longevity-Basis.

Rapamycin

mTOR-Inhibition, Langlebigkeits-Studien, Off-Label-Dosierung und Sicherheit.

AMPK Activators

Berberin, Alpha-Liponsäure, energetic stress und Glukose-Modulation.

ApoB

Bessere kardiovaskuläre Risiko-Metrik als LDL-C — moderne Lipidologie.

Autophagie

Zellulärer Selbstabbau — Fasten, Sport, Spermidin als Trigger.

Berberin

Glukose, Lipide, AMPK und GI-Verträglichkeits-Daten.

Biologisches Alter

GrimAge, PhenoAge, DunedinPACE — was Epigenetik-Uhren messen.

Caloric Restriction

CR-Mimetika, Lebensspannen-Forschung und NHP-Studien.

Krebsfrüherkennung

Empfehlungen, Über-Diagnose, Galleri-Tests, Ganzkörper-MRT (kritisch).

Zelluläre Seneszenz

„Zombie-Zellen", SASP, Senolytika-Ansätze.

Kollagen

Haut, Gelenke, Sehnen — Evidenz pro Hydrolysat plus Vitamin C.

Demenz-Prävention

Lifestyle-Faktoren: Bewegung, Schlaf, Hörgesundheit, Vaskuläre Gesundheit.

DEXA-Knochendichte

DEXA-Scan für Knochen + Körperzusammensetzung — Verlauf wichtiger als Einzelwert.

Epigenetische Uhren

Horvath, GrimAge, PhenoAge — was sie messen und nicht messen.

Epigenetik

DNA-Methylierung, Histon-Modifikationen, Umwelteinflüsse auf Genexpression.

Exosomen

Zell-Kommunikation, regenerative Anwendungen, frühes Forschungsfeld.

Genetiktests

Variants, Pharmacogenomik, Limitationen — Methylierung, MTHFR-Mythen.

Glucosamine

Gelenke, UK Biobank Mortalitäts-Studie, Sulfat vs HCl-Formen.

Glycin

Methylierung, Kollagensynthese, Lebensspannen-Hinweise in Tiermodellen.

Griffkraft

Starker Mortalitäts-Prädiktor — einfach messbar, trainierbar.

Verwandte Themen aus anderen Welten